Formation Bio
formation.bio
Actively hiring
Drug Discovery
Health Care
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Formation Bio Appoints Michael Ehlers As Chief Scientific Officer And Head Of R&D
Formation Bio has appointed Michael D. Ehlers, MD, PhD, as Chief Scientific Officer and Head of Research and Development. Ehlers will provide scientific leadership across Formation Bio's portfolio, from translational research through clinical development.
Read more
Report
Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor
Read more
Report
Report
Pro access
Upgrade to see all 23 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Linhao Zhang
Executive Officer, Director
Benjamine Liu
Executive Officer, Director
Alfred Lin
Director
Michael Moritz
Director
Scott Kupor
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York
United States
HQ
1000-5000 est. staff
Financials
Total raised
$372.2M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2024 | $372.2M | Details |